Saving Teva

By SHLOMO MAITAL
November 5, 2017 13:43

Why the pharmaceutical giant needs to be bailed out




Saving Teva

A building in Jerusalem belonging to generic drug producer Teva. (photo credit:REUTERS/BAZ RATNER)

ISRAEL’S FLAGSHIP global giant, Teva Pharmaceuticals, is in deep trouble.

From January 2016 to June 2017, Teva’s share price was cut in half. Then, in a few disastrous days in August, it was halved again.

Read More...

Related Content